Skip to content
Craig Kabrhel
← Productions

VAQTA demonstrated 100% efficacy against hepatitis A in the landmark Monroe study of 2 to 16-year-olds

In the Monroe study, VAQTA demonstrated 100% efficacy against hepatitis A

No cases of hepatitis A were reported after day 50.

In a 9-year follow-up study, no cases of hepatitis A were reported in those who received a second dose of VAQTA.

VAQTA 9-Year Study — video by Craig KabrhelVAQTA 9-Year Study
Still 1 from 9-Year Study by director Craig KabrhelStill 2 from 9-Year Study by director Craig KabrhelStill 3 from 9-Year Study by director Craig KabrhelStill 4 from 9-Year Study by director Craig KabrhelStill 5 from 9-Year Study by director Craig Kabrhel
Still 6 from 9-Year Study by director Craig KabrhelStill 7 from 9-Year Study by director Craig KabrhelStill 8 from 9-Year Study by director Craig KabrhelStill 9 from 9-Year Study by director Craig KabrhelStill 10 from 9-Year Study by director Craig Kabrhel
Still 11 from 9-Year Study by director Craig KabrhelStill 12 from 9-Year Study by director Craig KabrhelStill 13 from 9-Year Study by director Craig KabrhelStill 14 from 9-Year Study by director Craig KabrhelStill 15 from 9-Year Study by director Craig Kabrhel
Still 16 from 9-Year Study by director Craig KabrhelStill 17 from 9-Year Study by director Craig KabrhelStill 18 from 9-Year Study by director Craig KabrhelStill 19 from 9-Year Study by director Craig KabrhelStill 20 from 9-Year Study by director Craig Kabrhel
Still 21 from 9-Year Study by director Craig KabrhelStill 22 from 9-Year Study by director Craig KabrhelStill 23 from 9-Year Study by director Craig KabrhelStill 24 from 9-Year Study by director Craig KabrhelStill 25 from 9-Year Study by director Craig Kabrhel
Still 26 from 9-Year Study by director Craig KabrhelStill 27 from 9-Year Study by director Craig KabrhelStill 28 from 9-Year Study by director Craig KabrhelStill 29 from 9-Year Study by director Craig KabrhelStill 30 from 9-Year Study by director Craig Kabrhel
Still 31 from 9-Year Study by director Craig KabrhelStill 32 from 9-Year Study by director Craig KabrhelStill 33 from 9-Year Study by director Craig KabrhelStill 34 from 9-Year Study by director Craig KabrhelStill 35 from 9-Year Study by director Craig Kabrhel
Still 36 from 9-Year Study by director Craig KabrhelStill 37 from 9-Year Study by director Craig KabrhelStill 38 from 9-Year Study by director Craig KabrhelStill 39 from 9-Year Study by director Craig KabrhelStill 40 from 9-Year Study by director Craig Kabrhel
Next project JELMYTO → JELMYTO — next production